Gene Editing: Exa-Cel Panel Review Raises Practical Concerns About Theoretical Risks

 
• By Sue Sutter
Mountain terrain
The exa-cel adcomm found itself navigating new terrain of practical concerns befitting the cutting-edge technology involved. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers